The Innovation Firm

Gary L. Juskowiak II, Ph.D.

Practice Areas

Technologies

Education

  • University of Virginia, B.S. in Chemistry – Biochemistry, High Distinction
  • University of California, Irvine, Ph.D. in Organic Chemistry
  • University of California, Berkeley, School of Law, J.D.

Professional Associations

  • American Bar Association
  • California Bar Association

Gary L. Juskowiak II, Ph.D.

Gary L. Juskowiak II, Ph.D. Attorney

Gary L. Juskowiak II, Ph.D.

Associate
Concord office
978.341.0036

Gary prepares and prosecutes patent applications primarily in the fields of pharmaceuticals, chemicals, biotechnology and materials science. The pharmaceutical technologies include small molecule, protein and antibody pharmaceuticals. The chemical and materials science technologies include chemical catalysis, alloys, polymers, resins, coatings, films, optics, lithography, semiconductors, OLED displays, solar cells, fuel cells and batteries. The biotechnologies include biochips, microneedles, microparticles, bioassays, surgical membranes, transgenic animals, transgenic plants, tissues, stem cells, viruses, antibodies, vaccines, proteins, enzymes, saccharides, nucleotides, genetic sequencing, medical diagnostics, biofuels, cosmetics, supplements and implants.

Gary has counseled and prosecuted patent applications for multinational companies, research universities and start-up companies. He has practiced in law firms and in-house in an algae biotechnology company. He has particular experience managing global portfolios for small molecule pharmaceuticals. His experience also includes prosecuting the chemical and materials science aspects of clean technologies such as lithium ion batteries and solar cells. Additionally, he has worked on opinions and participated in inter partes review proceedings. Further, Gary prepared privacy guidelines for the ACLU of New Mexico to implement the Regional Center for Border Rights Program.

While at Berkeley Law, Gary earned the distinction of the Advocacy Award for Written and Oral Advocacy and participated in the Berkeley Technology Law Journal.

In graduate school at University of California, Irvine, Gary performed synthetic organic chemistry, peptide chemistry, combinatorial chemistry, analytical chemistry, biochemistry, and molecular biology research to discover and develop new forms of peptide reactivity.  He designed new methodologies in peptide synthetic and combinatorial chemistry and synthesized new fluorescent probes.  Additionally, he taught graduate and undergraduate labs and lecture courses. Further, Gary was awarded the NIH Ruth L. Kirschstein National Research Service Award and Fellowship and UCI Biotechnology Research and Education Program Fellowship.

As an undergraduate at University of Virginia, Gary performed synthetic organic chemistry, analytical chemistry and biochemistry research to improve anti-ischemia and antiepileptic pharmaceuticals and identify drug toxicity. He graduated with high distinction.

Publications and Speaking Engagements

  • Lecturer and author in the 2019, 2018, 2017, 2016 and 2015 Birch, Stewart, Kolasch and Birch Summer Patent Seminars
  • Juskowiak, Gary L., “Sequence-Specific Reactivity of Short Peptides: Peptide Photooxidative Fluorogenesis and Peptide Tags for Small Molecule Fluorescent Probes,” June 2009.
  • Juskowiak, Gary L.; McGee, Christopher J.; Greaves, John; Van Vranken, David L., J. Comb. Chem. 2008, 10, 726-731.
  • 2004 UCI Chemical Biology Symposium: September 2004.
  • Juskowiak, Gary L.; Stachel, Shawn J.; Tivitmahaisoon, Parcharee; Van Vranken, David L.,  J. Am. Chem. Soc. 2004, 126, 550-556.
  • Juskowiak, Gary L.; Stachel, Shawn J.; Tivitmahaisoon, Parcharee; Van Vranken, David L., 227th ACS National Meeting, Anaheim, CA, March 2004.
  • 2003 UCI Pfizer Organic Synthesis Symposium: September 2003.
  • Juskowiak, Gary L., “Progress Towards the Synthesis of Fluorofelbamate (2-Fluoro-2-phenyl-1,3-propanediol dicarbamate) Ring Analog Derivatives,” May 2001.

Bar Admissions

  • California
  • U.S. Patent and Trademark Office

Press Releases

  • Gary L. Juskowiak II, Ph.D., Joins Hamilton Brook Smith Reynolds’ Chemistry Practitioners more
Biography

Gary prepares and prosecutes patent applications primarily in the fields of pharmaceuticals, chemicals, biotechnology and materials science. The pharmaceutical technologies include small molecule, protein and antibody pharmaceuticals. The chemical and materials science technologies include chemical catalysis, alloys, polymers, resins, coatings, films, optics, lithography, semiconductors, OLED displays, solar cells, fuel cells and batteries. The biotechnologies include biochips, microneedles, microparticles, bioassays, surgical membranes, transgenic animals, transgenic plants, tissues, stem cells, viruses, antibodies, vaccines, proteins, enzymes, saccharides, nucleotides, genetic sequencing, medical diagnostics, biofuels, cosmetics, supplements and implants.

Gary has counseled and prosecuted patent applications for multinational companies, research universities and start-up companies. He has practiced in law firms and in-house in an algae biotechnology company. He has particular experience managing global portfolios for small molecule pharmaceuticals. His experience also includes prosecuting the chemical and materials science aspects of clean technologies such as lithium ion batteries and solar cells. Additionally, he has worked on opinions and participated in inter partes review proceedings. Further, Gary prepared privacy guidelines for the ACLU of New Mexico to implement the Regional Center for Border Rights Program.

While at Berkeley Law, Gary earned the distinction of the Advocacy Award for Written and Oral Advocacy and participated in the Berkeley Technology Law Journal.

In graduate school at University of California, Irvine, Gary performed synthetic organic chemistry, peptide chemistry, combinatorial chemistry, analytical chemistry, biochemistry, and molecular biology research to discover and develop new forms of peptide reactivity.  He designed new methodologies in peptide synthetic and combinatorial chemistry and synthesized new fluorescent probes.  Additionally, he taught graduate and undergraduate labs and lecture courses. Further, Gary was awarded the NIH Ruth L. Kirschstein National Research Service Award and Fellowship and UCI Biotechnology Research and Education Program Fellowship.

As an undergraduate at University of Virginia, Gary performed synthetic organic chemistry, analytical chemistry and biochemistry research to improve anti-ischemia and antiepileptic pharmaceuticals and identify drug toxicity. He graduated with high distinction.

Publications and Speaking Engagements

  • Lecturer and author in the 2019, 2018, 2017, 2016 and 2015 Birch, Stewart, Kolasch and Birch Summer Patent Seminars
  • Juskowiak, Gary L., “Sequence-Specific Reactivity of Short Peptides: Peptide Photooxidative Fluorogenesis and Peptide Tags for Small Molecule Fluorescent Probes,” June 2009.
  • Juskowiak, Gary L.; McGee, Christopher J.; Greaves, John; Van Vranken, David L., J. Comb. Chem. 2008, 10, 726-731.
  • 2004 UCI Chemical Biology Symposium: September 2004.
  • Juskowiak, Gary L.; Stachel, Shawn J.; Tivitmahaisoon, Parcharee; Van Vranken, David L.,  J. Am. Chem. Soc. 2004, 126, 550-556.
  • Juskowiak, Gary L.; Stachel, Shawn J.; Tivitmahaisoon, Parcharee; Van Vranken, David L., 227th ACS National Meeting, Anaheim, CA, March 2004.
  • 2003 UCI Pfizer Organic Synthesis Symposium: September 2003.
  • Juskowiak, Gary L., “Progress Towards the Synthesis of Fluorofelbamate (2-Fluoro-2-phenyl-1,3-propanediol dicarbamate) Ring Analog Derivatives,” May 2001.
Education
  • University of Virginia, B.S. in Chemistry – Biochemistry, High Distinction
  • University of California, Irvine, Ph.D. in Organic Chemistry
  • University of California, Berkeley, School of Law, J.D.
Professional Associations
  • American Bar Association
  • California Bar Association
News
  • Gary L. Juskowiak II, Ph.D., Joins Hamilton Brook Smith Reynolds’ Chemistry Practitioners more
Bar Admissions
  • California
  • U.S. Patent and Trademark Office

Back to the Top